{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:35:54Z","timestamp":1772825754017,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmc.2025.118095","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:07:04Z","timestamp":1738627624000},"page":"118095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rational design and synthesis of pyrazole derivatives as potential SARS-CoV-2 Mpro inhibitors: An integrated approach merging combinatorial chemistry, molecular docking, and deep learning"],"prefix":"10.1016","volume":"120","author":[{"given":"Arthur Antunes","family":"Ferrarezi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o V\u00edtor Perez","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Maigret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rika Seki","family":"Kioshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidnei","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arildo Jos\u00e9 Braz","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Andreia","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina Aparecida Correia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118095_b0005","unstructured":"Coronavirus Disease (COVID-19) Situation Reports. Accessed January 15, 2025. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"10.1016\/j.bmc.2025.118095_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-024-02013-8","article-title":"Current progress, challenges and prospects in the development of COVID-19 vaccines","volume":"84","author":"Zhu","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2025.118095_b0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 vaccine: first approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2025.118095_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1544","article-title":"The WHO has declared the end of pandemic phase of COVID-19: way to come back in the normal life","volume":"6","author":"Sarker","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.bmc.2025.118095_b0025","first-page":"276","article-title":"Crystal structures of coronaviral main proteases in complex with the non-covalent inhibitor X77","author":"Jiang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2025.118095_b0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm301580n","volume":"56","author":"Jacobs","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0035","doi-asserted-by":"crossref","unstructured":"Joshi S, Joshi M, Degani MS. Tackling SARS-CoV-2: proposed targets and repurposed drugs. Future Med Chem. Published online June 22, 2020. doi:10.4155\/fmc-2020-0147.","DOI":"10.4155\/fmc-2020-0147"},{"key":"10.1016\/j.bmc.2025.118095_b0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2025.118095_b0045","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases. Bjorkman P, ed","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bmc.2025.118095_b0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.bmc.2025.118095_b0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118095_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2025.118095_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-021-00643-z","article-title":"SARS-CoV-2: from its discovery to genome structure, transcription, and replication","volume":"11","author":"Brant","year":"2021","journal-title":"Cell Biosci"},{"key":"10.1016\/j.bmc.2025.118095_b0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","article-title":"SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging","volume":"17","author":"Rut","year":"2021","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2025.118095_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102667","article-title":"Structural biology of SARS-CoV-2 Mpro and drug discovery","volume":"82","author":"Duan","year":"2023","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.bmc.2025.118095_b0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/md18040225","article-title":"Putative inhibitors of SARS-CoV-2 main protease from A library of marine natural products: a virtual screening and molecular modeling study","volume":"18","author":"Gentile","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.bmc.2025.118095_b0085","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1039\/D0SC02823A","article-title":"Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM\/MM computational methods","volume":"11","author":"\u015awiderek","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2025.118095_b0090","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/molecules27082523","article-title":"Advances in the development of SARS-CoV-2 Mpro inhibitors","volume":"27","author":"Agost-Beltr\u00e1n","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118095_b0095","doi-asserted-by":"crossref","unstructured":"Jin Z, Du X, Xu Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 2020 582:7811. 2020;582(7811):289-293. doi:10.1038\/s41586-020-2223-y.","DOI":"10.1038\/s41586-020-2223-y"},{"key":"10.1016\/j.bmc.2025.118095_b0100","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"\u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0105","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2025.118095_b0110","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbrc.2005.02.061","article-title":"The substrate specificity of SARS coronavirus 3C-like proteinase","volume":"329","author":"Fan","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2025.118095_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013197","article-title":"Profiling of substrate specificity of SARS-CoV 3CLpro","volume":"5","author":"Chuck","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118095_b0120","first-page":"1763","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science (1979)"},{"key":"10.1016\/j.bmc.2025.118095_b0125","doi-asserted-by":"crossref","unstructured":"Jain RP, Pettersson HI, Zhang J, et al. Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro. J Med Chem 47; 2004:6113-6116. doi:10.1021\/jm0494873.","DOI":"10.1021\/jm0494873"},{"key":"10.1016\/j.bmc.2025.118095_b0130","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1021\/jm050548m","article-title":"Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors","volume":"48","author":"Ghosh","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0135","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1021\/jm0603926","article-title":"Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor","volume":"49","author":"Yang","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0140","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/jm061425k","article-title":"Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters","volume":"50","author":"Zhang","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0145","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design","volume":"82","author":"Xue","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2025.118095_b0150","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1021\/jm050184y","article-title":"Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease","volume":"48","author":"Shie","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0155","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jm0501782","article-title":"A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods","volume":"48","author":"Kaeppler","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0160","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease","volume":"49","author":"Lu","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0165","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/jm0507678","article-title":"Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors","volume":"49","author":"Zhang","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0170","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/acs.jmedchem.5b01013","article-title":"Cyanohydrin as an anchoring group for potent and selective inhibitors of enterovirus 71 3C protease","volume":"58","author":"Zhai","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0175","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/acs.jcim.0c00179","article-title":"Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study","volume":"60","author":"Wang","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2025.118095_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118275","article-title":"Utilizing drug repurposing against COVID-19 \u2013 efficacy, limitations, and challenges","volume":"259","author":"Parvathaneni","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2025.118095_b0185","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.drudis.2020.04.005","article-title":"Boosting the arsenal against COVID-19 through computational drug repurposing","volume":"25","author":"Ciliberto","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2025.118095_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117652","article-title":"In silico studies on therapeutic agents for COVID-19: drug repurposing approach","volume":"252","author":"Shah","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2025.118095_b0195","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2021.0018","article-title":"Pandemic drugs at pandemic speed: Infrastructure for accelerating COVID-19 drug discovery with hybrid machine learning- and physics-based simulations on high-performance computers","volume":"11","author":"Bhati","year":"2021","journal-title":"Interface Focus"},{"key":"10.1016\/j.bmc.2025.118095_b0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbpa.2017.03.017","article-title":"Combinatorial chemistry in drug discovery","volume":"38","author":"Liu","year":"2017","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmc.2025.118095_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105350","article-title":"Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization","volume":"204","author":"Mercorelli","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2025.118095_b0210","article-title":"Miniaturized modular click chemistry-enabled rapid discovery of unique SARS-CoV-2 mpro inhibitors with robust potency and drug-like profile","author":"Yang","year":"2024","journal-title":"Adv Sci Published Online"},{"key":"10.1016\/j.bmc.2025.118095_b0215","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1021\/acs.jcim.3c01466","article-title":"DiffDec: structure-aware scaffold decoration with an end-to-end diffusion model","volume":"64","author":"Xie","year":"2024","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2025.118095_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-020-00441-8","article-title":"SMILES-based deep generative scaffold decorator for de-novo drug design","volume":"12","author":"Ar\u00fas-Pous","year":"2020","journal-title":"J Cheminform"},{"key":"10.1016\/j.bmc.2025.118095_b0225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/qsar.200630101","article-title":"SmiLib v2.0: a Java-based tool for rapid combinatorial library enumeration","volume":"26","author":"Sch\u00fcller","year":"2007","journal-title":"QSAR Comb Sci"},{"key":"10.1016\/j.bmc.2025.118095_b0230","doi-asserted-by":"crossref","unstructured":"Frank \u00c9, Sz\u0151ll\u0151si G. Nitrogen-Containing Heterocycles as Significant Molecular Scaffolds for Medicinal and Other Applications. Vol 26. MDPI AG; 2021. doi:10.3390\/molecules26154617.","DOI":"10.3390\/molecules26154617"},{"key":"10.1016\/j.bmc.2025.118095_b0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jhet.3045","article-title":"4-Formyl-pyrazole-3-carboxylate: a useful aldo-X bifunctional precursor for the syntheses of pyrazole-fused\/substituted frameworks","volume":"55","author":"Devi","year":"2018","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0240","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bmcl.2012.12.094","article-title":"Design, synthesis, characterization and anti-inflammatory evaluation of novel pyrazole amalgamated flavones","volume":"23","author":"Chavan","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118095_b0245","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ejmech.2014.12.013","article-title":"Novel pyrazole-5-carboxamide and pyrazole\u2013pyrimidine derivatives: synthesis and anticancer activity","volume":"90","author":"Shi","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0250","unstructured":"Patil A, Jadhav R, Raundal H, et al. Synthesis and Antifungal Activity of 1, 5-Diaryl Pyrazole Substituted Thiazole Derivatives. Vol 54.; 2015."},{"key":"10.1016\/j.bmc.2025.118095_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115835","article-title":"Efficient synthesis and antitumor evaluation of 4-aminomethyl-N-arylpyrazoles: discovery of potent and selective agents for ovarian cancer","volume":"29","author":"da Silva","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.591570","article-title":"Antiparasitic behavior of trifluoromethylated pyrazole 2-amino-1,3,4-thiadiazole hybrids and their analogues, synthesis and structure-activity relationship","volume":"11","author":"Camargo","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2025.118095_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105082","article-title":"Discovery of 1,3,4,5-tetrasubstituted pyrazoles as anti-trypanosomatid agents: Identification of alterations in flagellar structure of L. amazonensis","volume":"114","author":"da Silva","year":"2021","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bmc.2025.118095_b0270","first-page":"2657","article-title":"Potential antileishmanial activity of 4-N-acylhydrazone pyrazolo[3,4-d]pyridazin-7-ones: synthesis, in vitro biological evaluations and computational studies","volume":"29","author":"Jacomini","year":"2018","journal-title":"J Braz Chem Soc"},{"key":"10.1016\/j.bmc.2025.118095_b0275","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1039\/C5RA12968K","article-title":"Theoretical and experimental investigation of the polyeletrophilic \u03b2-enamino diketone: Straightforward and highly regioselective synthesis of 1,4,5-trisubstituted pyrazoles and pyrazolo[3,4-d]pyridazinones","volume":"6","author":"Da Silva","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118095_b0280","doi-asserted-by":"crossref","first-page":"12590","DOI":"10.1021\/acs.joc.7b02361","article-title":"Unconventional method for synthesis of 3-carboxyethyl-4-formyl(hydroxy)-5-aryl- N -arylpyrazoles","volume":"82","author":"da Silva","year":"2017","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmc.2025.118095_b0285","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ajoc.201700048","article-title":"Regiochemical control of pyrazoles by solvent and \u03b2-enamino diketone structure: regioselective synthesis of 4,5-disubstituted N-phenylpyrazoles","volume":"6","author":"Souza","year":"2017","journal-title":"Asian J Org Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0290","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0295","unstructured":"St. John SE, Mesecar AD. BROAD-SPECTRUM NON-COVALENT CORONAVIRUS PROTEASE INHIBITORS. 2017;(43):1-39. Accessed November 27, 2024. https:\/\/patents.google.com\/patent\/US20170313685A1\/en."},{"key":"10.1016\/j.bmc.2025.118095_b0300","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2025.118095_b0305","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/bioinformatics\/btaa1005","article-title":"DeepPurpose: a deep learning library for drug-target interaction prediction","volume":"36","author":"Huang","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bmc.2025.118095_b0310","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad218","article-title":"Uni-GBSA: an open-source and web-based automatic workflow to perform MM\/GB(PB)SA calculations for virtual screening","volume":"24","author":"Yang","year":"2023","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.bmc.2025.118095_b0315","first-page":"7","article-title":"A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118095_b0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2025.118095_b0325","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0330","unstructured":"Armarego WLF, Perrin DD (Douglas D. Purification of Laboratory Chemicals. Butterworth Heinemann; 1997."},{"key":"10.1016\/j.bmc.2025.118095_b0335","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1055\/s-2008-1078482","article-title":"Straightforward and regiospecific synthesis of pyrazole-5-carboxylates from unsymmetrical enaminodiketones","volume":"2008","author":"Rosa","year":"2008","journal-title":"Synlett"},{"key":"10.1016\/j.bmc.2025.118095_b0340","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1055\/s-2007-992382","article-title":"N- and C-acylation in \u03b2-enamino ketones: structural effects on regiocontrol","volume":"2007","author":"Rosa","year":"2007","journal-title":"Synlett"},{"key":"10.1016\/j.bmc.2025.118095_b0345","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1021\/jacs.1c08402","article-title":"Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses","volume":"144","author":"Luttens","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118095_b0350","first-page":"7","article-title":"Identification of novel 3-hydroxy-pyran-4-one derivatives as potent HIV-1 integrase inhibitors using in silico structure-based combinatorial library design approach","author":"Sirous","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2025.118095_b0355","first-page":"1","article-title":"Virtual combinatorial library screening of quinadoline B derivatives against SARS-CoV-2 RNA-dependent RNA polymerase","volume":"7","author":"Brogi","year":"2022","journal-title":"Computation"},{"key":"10.1016\/j.bmc.2025.118095_b0360","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.bmc.2025.118095_b0365","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1002\/adsc.202301018","article-title":"Contemporary approaches for amide bond formation","volume":"365","author":"Acosta-Guzm\u00e1n","year":"2023","journal-title":"Adv Synth Catal."},{"key":"10.1016\/j.bmc.2025.118095_b0370","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1590\/S0103-50532011001100023","article-title":"DBU as a catalyst for the synthesis of amides via aminolysis of methyl esters","volume":"22","author":"de Lima","year":"2011","journal-title":"J Braz Chem Soc."},{"key":"10.1016\/j.bmc.2025.118095_b0375","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1139\/cjc-2018-0234","article-title":"Facile direct synthesis of amides from trichloroethyl esters using catalytic DBU","volume":"96","author":"La","year":"2018","journal-title":"Can J Chem."},{"key":"10.1016\/j.bmc.2025.118095_b0380","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3762\/bjoc.16.46","article-title":"Exploring the scope of DBU-promoted amidations of 7-methoxycarbonylpterin","volume":"16","author":"Bockman","year":"2020","journal-title":"Beilstein J Org Chem."},{"key":"10.1016\/j.bmc.2025.118095_b0385","doi-asserted-by":"crossref","first-page":"11140","DOI":"10.1021\/acs.joc.3c01117","article-title":"Controlled pyrazole-hydrazone annulation: regiodivergent synthesis of 1 H - and 2 H -pyrazolo[3,4- d ]pyridazinones","volume":"88","author":"Rosa","year":"2023","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmc.2025.118095_b0390","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1021\/acs.joc.1c02622","article-title":"Cp*Rh(III)-catalyzed regioselective C(sp2)-H mono- and dialkynylation of thioamides by sulfur coordination","volume":"87","author":"Ma","year":"2022","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmc.2025.118095_b0395","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/asia.201800759","article-title":"Ruthenium-pincer-catalyzed hydrogenation of lactams to amino alcohols","volume":"13","author":"Chen","year":"2018","journal-title":"Chem Asian J."},{"key":"10.1016\/j.bmc.2025.118095_bib396","doi-asserted-by":"crossref","unstructured":"Barreiro E. J. In: Br\u00e4se S., ed. The Royal Society of Chemistry; 2015, ch: 1\u201315 . Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation.1.","DOI":"10.1039\/9781782622246-00001"},{"issue":"3","key":"10.1016\/j.bmc.2025.118095_bib397","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","article-title":"Prediction of drug solubility from structure","volume":"54","author":"Jorgensen","year":"2002","journal-title":"Adv. Drug Delivery Rev."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:23:29Z","timestamp":1740461009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":81,"alternative-id":["S0968089625000367"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118095","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design and synthesis of pyrazole derivatives as potential SARS-CoV-2 Mpro inhibitors: An integrated approach merging combinatorial chemistry, molecular docking, and deep learning","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118095"}}